pioglitazone has been researched along with Inclusion Body Myopathy, Sporadic in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The sporadic form of inclusion body myositis (IBM) is the most common late-onset myopathy." | 2.61 | Sporadic Inclusion Body Myositis: An Acquired Mitochondrial Disease with Extras. ( De Paepe, B, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Paepe, B | 1 |
1 review available for pioglitazone and Inclusion Body Myopathy, Sporadic
| Article | Year |
|---|---|
Sporadic Inclusion Body Myositis: An Acquired Mitochondrial Disease with Extras.
Topics: Biomarkers; Cytokines; DNA, Mitochondrial; Growth Differentiation Factor 15; Humans; Hypoglycemic Ag | 2019 |